Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer
Go back to Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 66.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.05 | 52 Week High | $77.12 | |||
| Open | $66.05 | 52 Week Low | $49.03 | |||
| Day High | $66.05 | P/E | 42.89 | |||
| Day Low | $66.05 | EPS | $1.54 | |||
| Volume | 16,690 | |||||
